November 8, 2013

When the maker of a branded drug updates the safety information on its product labeling, makers of generic versions of that drug must wait until the Food and Drug Administration approves the new labeling before they can update theirs, but that could soon change under a rule proposed by the FDA.

November 8, 2013

It’s called medication synchronization, and the concept is simple enough — shifting patients to a synchronized, easy-to-comply-with, once-a-month prescription refill program so they can pick up all their medications with one visit to the pharmacy each month, instead of multiple trips.

November 8, 2013

Like any company looking to stage a turnaround, Rite Aid has employed multiple tactics to return to profitability and win back investors’ favor, but few of those programs have been as important to the chain’s efforts as its loyalty card program.

November 8, 2013

The Senate this past week heard legislation that would reverse the provision of the Patient Protection and Affordable Care Act mandating a prescription on the sale of an over-the-counter medicine being paid for through a flexible spending account. All those in the retail pharmacy industry are staunch supporters of the legislation.

And that's because retail pharmacy gets it. It's not about the sales — has anyone ever heard of a consumer who decided not to purchase a pain reliever or cough syrup because it wasn't an eligible FSA purchase without a trip to their doctor? No. That person doesn't exist — they'll buy the same amount of OTCs to cure what's ailing them with an FSA as without an FSA. No, it's about the value inherent within OTCs. It's about tapping into that value to the benefit of both consumers and overall health care.

November 8, 2013

The United States is leading in its preference for generic drugs. According to a new report by Rhinebeck, N.Y.-based Phoenix Marketing International, 37% of American consumers expressed a preference for generic drugs when they were available, compared with 22% of the French, 21% of Canadians and 12% of Britons. The study was based on 810 consumers in the four countries.

November 8, 2013
Higi ‘scores’ with kiosks

Through its biometric screening kiosks, its smartphone application and its website, Higi encourages users to take a more holistic approach to their health. True wellness, its creators insist, springs not just from such physical metrics as blood pressure, glucose readings and body mass index, but from lifestyle choices and connections to family, friends, neighbors and coworkers.

November 7, 2013

Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take.

November 6, 2013

State legislators in Michigan are considering a bill that would allow pharmacies to sell medical marijuana, according to published reports.

November 5, 2013

The Food and Drug Administration has approved a generic injectable antibiotic drug made by Emcure Pharmaceuticals, according to the agency.

November 5, 2013

The Food and Drug Administration has approved a generic drug made by Mylan for treating overactive bladder, according to agency records.

November 5, 2013

Walgreens on Tuesday posted October sales of $6.4 billion, an increase of 6.1%. Sales in comparable stores increased by 5.8% in October.

November 5, 2013

Walgreens and Alliance Boots on Tuesday announced that Richard Ashworth, Walgreens corporate operations VP for the Western United States, has been appointed as director of health care, health and beauty U.K. and Republic of Ireland at Alliance Boots.

November 4, 2013

Silvergate Pharmaceuticals has launched a new drug for treating high blood pressure in children, the company said Monday.

November 4, 2013

The Food and Drug Administration has asked Ariad Pharmaceuticals to suspend marketing and sales of a chemotherapy drug for leukemia due to the risk of life-threatening side effects, the agency said.

November 1, 2013

Indian drug maker Dr. Reddy's Labs had sales of $536 million in second quarter 2014 and profits of $110 million, the company said.

November 1, 2013

The Food and Drug Administration has approved a new drug for leukemia made by Genentech, the agency said Friday.

November 1, 2013

Mylan expects to be the first to market with a generic version of a drug for treating patients with gout, the company said Friday, though its filing has triggered a lawsuit from the makers of the branded version.

November 1, 2013

The Food and Drug Administration has released a new video that warns consumers against buying drugs from rogue-internet pharmacies, part of the ongoing effort by the agency to keep fake and contaminated drugs out of the U.S. supply chain.

November 1, 2013

A new study by IMS Health finds that most apps focused on health and wellness have limited functionality or evidence of value in advancing healthcare provision and outcomes, with fewer than half of them directly related to patient health and treatment, and more than half of them having fewer than 500 downloads.

With more than 43,000 health-and-wellness apps from the Apple App Store alone included in the IMS study, but a dearth of apps for elderly patients with chronic conditions, there is ample opportunity for developers to address this need. That will become especially important as health care becomes increasingly focused on patient outcomes. And this means opportunities for apps that address the ever-present issue of poor medication adherence.

November 1, 2013

Teva Pharmaceutical Industries had $5.1 billion in sales and $711 million in profits in third-quarter 2013, the Israeli drug maker said.

October 31, 2013

Actavis is seeking Food and Drug Administration approval for a generic drug used to treat acne, triggering a lawsuit in a federal court from the maker of the branded version, the company said Thursday.

October 31, 2013

The Food and Drug Administration is using long-term strategies to address drug shortages when they appear and requiring manufacturers to notify the agency if a shortage is at risk of happening, under a new plan announced Thursday.

October 31, 2013

Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze gel.

October 31, 2013

A personalized medicine company said a new study justifies clinical use of pharmacogenomic testing to help predict patients' response to psychiatric medications and improve treatment outcomes.